Association of BMI With Benefit of Metformin Plus Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients With Advanced Lung Adenocarcinoma: A Secondary Analysis of a Phase 2 Randomized Clinical Trial

Saved in:
Bibliographic Details
Published inJAMA oncology Vol. 8; no. 3; p. 477
Main Authors Arrieta, Oscar, Zatarain-Barrón, Zyanya Lucia, Turcott, Jenny G, Barrón, Feliciano, Yendamuri, Sai, Cardona, Andrés F, Rosell, Rafael
Format Journal Article
LanguageEnglish
Published United States 01.03.2022
Subjects
Adenocarcinoma of Lung - drug therapy
Body Mass Index
ErbB Receptors - genetics
Humans
Lung Neoplasms - drug therapy
Metformin - therapeutic use
Mutation
Protein Kinase Inhibitors - adverse effects
Online AccessGet more information

Cover

More Information
ISSN:2374-2445
DOI:10.1001/jamaoncol.2021.7015